Hyaluronic Acid for Penile Enlargement: Why HA Beats PMMA in 2026

Introduction: The Filler Decision Is Made. Now the Real Decision Begins

Most men reading this page have already moved past the basic question of what penile filler is. They have ruled out surgery, reviewed before-and-after galleries, and are now comparing materials before booking a consultation. For many accomplished professionals who once assumed no discreet, credible solution existed, this is the point where research turns into a real decision.

The question is narrower now: hyaluronic acid (HA, such as Belefil®), PMMA, or silicone? Which material delivers on safety, satisfaction, and long-term outcome, rather than on marketing claims?

This page answers that question with peer-reviewed randomized controlled trials, retrospective cohorts, and FDA classification data instead of brand superlatives. The thesis is simple: HA produces girth gains statistically comparable to permanent-leaning alternatives, with a safety and reversibility profile that PMMA and silicone cannot structurally match.

The timing matters. Practitioners describe penile girth enhancement as one of the fastest-growing procedures in men’s aesthetic medicine, sometimes calling it the “Male BBL.” Industry forecasts project the global dermal filler market to grow from roughly $4.1 billion in 2025 to $7.3 billion by 2030, with HA leading because of its biocompatibility and reversibility. As demand rises, choosing the right material carefully becomes more important than ever.

The Three Materials on the Table: A Structural Comparison

Patients are realistically choosing among three categories:

• Hyaluronic acid (Belefil®): A biodegradable, cross-linked glycosaminoglycan. The body recognizes it, metabolizes it gradually, and it can be dissolved on demand with an enzyme.
• PMMA (polymethyl methacrylate microspheres): Permanent, non-biodegradable plastic microspheres suspended in a carrier gel.
• Liquid injectable silicone (LIS): Permanent, non-biodegradable silicone droplets.

The key difference is chemical. The body processes HA over time, while it walls off PMMA and silicone as foreign materials and keeps them encapsulated indefinitely. Every comparison that follows, including efficacy, satisfaction, safety, reversibility, regulatory status, and price, traces back to that single difference.

Does HA Actually Deliver Comparable Girth Gains? The Data Says Yes

The common objection to HA is that a material the body eventually metabolizes cannot match a permanent one. The clinical literature does not support that objection.

The 155-patient retrospective. A study published in The Journal of Sexual Medicine followed 155 men treated with HA filler. Key results:

• Average girth increase of 0.633 cm per treatment (12.5 syringes over 2.2 treatments on average)
• Average increase of 1.8 cm for men who received multiple treatments
• Average increase of 2.952 cm for the 23 men who completed four or more treatments
• Only 12.3% needed correction with hyaluronidase or Botox

The nearly 500-patient review. A retrospective analysis of almost 500 men using an HA-based filler system, presented at the Sexual Medicine Society of North America’s Fall Scientific Meeting, found the treatment safe with limited adverse events at scale.

The head-to-head blinded RCT. A multicenter, patient- and evaluator-blinded randomized trial published in the World Journal of Men’s Health compared HA with polylactic acid (PLA), a longer-lasting, permanent-leaning alternative. Mean girth increase was 22.74 mm for HA versus 20.23 mm for PLA, with no statistically significant difference. Both groups also improved on ejaculation-related measures (PEP index and IELT). The longer-lasting material did not produce better results.

Durability beyond year one. An 18-month non-inferiority RCT comparing HA and PLA tracked girth and satisfaction at baseline and at 1, 3, 6, and 18 months. HA’s durability held well past the first year.

The Satisfaction-Permanence Paradox: Why Bigger Isn’t Always Better

The most important study for this comparison is a 2024 comparative analysis of 301 patients.

In that study, PMMA produced the largest raw girth increase, yet PMMA patients reported lower satisfaction scores than HA recipients. The reason given was feel: PMMA creates a harder, less natural texture in both flaccid and erect states, which works against the outcome men care about most: a result that looks and feels like their own anatomy.

The conclusion follows directly. A permanent result a patient dislikes is a permanent problem. A natural-feeling HA result that can be refined or dissolved remains under the patient’s control.

This matches the treatment philosophy at Stoller Medical Group, which prioritizes proportion, balance, and natural look and feel over maximum volume.

Reversibility: The Structural Advantage PMMA and Silicone Cannot Offer

Reversibility is the single biggest difference between Belefil and every permanent alternative.

How it works. The enzyme hyaluronidase breaks down HA’s glycosaminoglycan structure, dissolving the filler when needed. A 2026 review in the Journal of Cosmetic Dermatology notes that higher concentrations can clear HA plugs associated with vascular occlusion in emergencies.

Two practical uses:

1. Elective correction. Asymmetry, contour irregularities, or overcorrection can be adjusted or dissolved.
2. Emergency management. If filler blocks a blood vessel, hyaluronidase can restore blood flow. Published protocols call for reconstituting 1500 IU in 10 ml of 0.9% sodium chloride, repeated every 30 to 60 minutes until reperfusion is achieved.

The contrast. PMMA and silicone have no enzymatic antidote. Once injected, correction requires surgical excision, which carries a risk of scarring and often cannot remove all of the material.

What Happens When Permanent Fillers Go Wrong: The PMMA and Silicone Risk Profile

An integrative review of 587 PMMA complication reports, published in the Revista Brasileira de Cirurgia Plástica, documented severe complications, including cases that required surgical removal.

Documented complications for PMMA and liquid silicone include:

• Vascular occlusion
• Infection
• Nodule and granuloma formation
• Systemic effects, including hypercalcemia and renal failure

These complications tend to persist because the body cannot break down PMMA microspheres or silicone droplets. Foreign body giant cells remain around the material indefinitely, which can cause chronic granulomatous reactions.

Other longer-lasting materials carry related risks. Three published case reports describe foreign body granuloma after polylactic acid injection for penile girth enhancement, which suggests caution with any permanent-leaning filler.

These are not rare historical anecdotes. They are documented, peer-reviewed, ongoing risk categories specific to non-biodegradable materials.

The FDA’s Own Position on Injectable Silicone

The FDA classifies silicone oil injected in amounts above 5 mg as a medical device, not a dermal filler. That is a different and more serious regulatory category.

The agency has also warned explicitly against injectable silicone for body augmentation. Published case reports describe the worst outcomes, including penile amputation.

This assessment comes from the federal government, not from competitors or marketing.

The Off-Label Truth Competitors Don’t Tell You: Neither HA Nor PMMA Is “FDA-Approved” for This Use

PMMA marketing often implies that the material is “FDA-approved” for penile enhancement. That is misleading.

• The only FDA-approved PMMA filler in the U.S., Bellafill, received premarket approval only for nasolabial folds and acne scars. It is not approved for penile augmentation.
• FDA-approved HA fillers are likewise cleared only for facial indications, so penile use of HA is also off-label.

Off-label use is standard, disclosed practice across this specialty for every material. The meaningful question is not which material has a facial FDA approval to cite. It is which material has the stronger peer-reviewed safety and efficacy evidence for this off-label use. On that measure, HA leads, supported by randomized trials and cohorts of hundreds of patients.

Practices that state this openly are giving patients accurate information. Practices that obscure it are not.

Why Belefil Specifically: The Material Science Behind the Choice

Belefil® is a medical-grade, cross-linked hyaluronic acid filler designed for soft tissue augmentation. It is biocompatible and has predictable rheology (how the gel flows and holds its shape). Its evidence base is the HA-class research described above: the 155-patient cohort, the nearly 500-patient review, and the randomized trials.

Practical advantages for patients:

• Faster recovery: Patients are typically back on their feet in about 10 days, compared with 40+ days reported for permanent filler alternatives. Sexual activity can usually resume within 7 to 10 days.
• Natural look and feel in both flaccid and erect states, which addresses the main weakness identified in the satisfaction-permanence data.
• Preserved sensation and function.
• Immediate visible enhancement, with results typically lasting 18 to 24 months.

Technique also matters. In 2026, the field increasingly uses blunt-tipped cannulas instead of sharp needles to lower the risk of vascular occlusion. Refined single-entry and contouring methods are also documented as improvements over older multi-entry approaches. Combining a reversible material with these techniques adds two layers of protection.

Why This Provider: Dr. Stoller’s 15,000+ Procedure Record

Choosing the material is half the decision. Choosing the provider is the other half.

Dr. Roy B. Stoller, founder of Stoller Medical Group, is a board-certified physician who has performed more than 15,000 enlargement procedures. He has 25+ years in aesthetic and restorative medicine, including 5 years focused specifically on non-surgical male enhancement.

That volume has practical benefits. Detailed familiarity with penile vascular anatomy lowers the risk of occlusion, which supports the safety case made throughout this page.

The practice also declines to offer surgical penile lengthening because of its higher risk. That decision reflects a safety-first clinical approach rather than a sales strategy. The practice’s staged, conservative treatment protocol aligns with the 155-patient data, where cumulative gains grew with each treatment.

Transparent Belefil Pricing by Enhancement Tier

Belefil penile enhancement starts at $7,500 and increases with the level of enhancement desired. Pricing is per syringe. Most men start with at least 10 syringes, and the average first procedure uses 15 syringes.

Many competitors offer only vague ranges or a quote at consultation. This itemized structure lets patients compare options with confidence before visiting. Follow-up and touch-up sessions are priced separately and discussed at the 2 to 3 month follow-up appointment.

Who Should (and Shouldn’t) Be Choosing a Filler Material Right Now

Size perception deserves an honest mention. Research shows that 85% of women are satisfied with their partner’s size, compared with only 55% of men with their own, and most men seeking enlargement measure average or above.

Studies also suggest that roughly 30% of men seeking enlargement may have Penile Dysmorphic Disorder (PDD). Satisfaction after surgical enlargement is low, around 35% overall and 27% among men with PDD.

For men who are proceeding carefully but want the option to correct course if their expectations or feelings change after treatment, HA’s reversibility makes it the lower-risk and more appropriate choice. Stoller Medical Group addresses this during its comprehensive consultation and informed consent process. The goal is to set realistic expectations, not to turn away legitimate candidates.

Conclusion: The Evidence-Based Case for HA Over Permanent Fillers

The evidence points in one direction:

• Comparable efficacy: HA matched a permanent-leaning alternative in a blinded RCT (22.74 mm versus 20.23 mm, no significant difference), and its durability held at 18 months.
• Higher satisfaction: PMMA produced larger raw gains but lower satisfaction because of its unnatural feel, while HA patients reported greater satisfaction.
• Reversibility: Hyaluronidase allows elective correction and emergency treatment of vascular occlusion. No permanent material offers this.
• Honest regulatory context: HA and PMMA are both off-label for penile use. What separates them is the depth of peer-reviewed evidence and the experience of the provider.

In short, the case rests on four parts: the right material (Belefil HA), solid clinical data, an experienced provider with 15,000+ procedures, and a transparent price starting at $7,500.

Schedule Your Belefil Consultation with Dr. Stoller

Men who have finished their research can book a free, confidential consultation to review candidacy, choose an enhancement tier, and receive an exact syringe count and price based on their goals.

In-person evaluations are available at five locations:

• Manhattan: 515 Madison Avenue, Suite 1205, New York, NY
• Long Island: 366 N Broadway, Suite LE2, Jericho, NY
• Albany: 1202 Troy Schenectady Road, Building No. 2, Latham, NY
• Pennsylvania: 1212 Baltimore Pike, Chadds Ford, PA
• Minnesota: 2121 Cliff Drive, Suite 210, Eagan, MN

Every consultation includes complete discretion, hospital-grade sterility protocols, and a thorough informed consent process. The next step is a private conversation with Dr. Stoller about whether Belefil is the right fit.